Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema

Chinese Medical Journal, 02/08/2011

Intravitreal injection of bevacizumab combined with/without triamcinolone acetonide had a beneficial effect on diabetic macular edema (DME). The results showed that no significant differences were detected between intravitreal bevacizumab combined with/without triamcinolone acetonide for the eyes with diabetic macular edema in Chinese patients.

Print Article Summary Cat 2 CME Report